Erratum: Developmental influence of the serotonin transporter on the expression of Npas4 and GABAergic markers: Modulation by antidepressant treatment (Neuropsychopharmacology (2011) doi:10.1038/npp.2011.252));Developmental influence of the serotonin transporter on the expression of Npas4 and GABAergic markers: Modulation by antidepressant treatment

Neuropsychopharmacology

Volumn 37, Issue 3, 2012, Pages 746-758

  Guidotti, Gianluigi ^a   Calabrese, Francesca ^a   Auletta, Francesca ^a   Olivier, Jocelien ^b   Racagni, Giorgio ^a   Homberg, Judith ^c   Riva, Marco A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c RADBOUD UNIVERSITY   (Netherlands)

Author keywords

depression; development; duloxetine; GABA; SERT; transcription factors

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; CALCIUM BINDING PROTEIN; DULOXETINE; GLUTAMATE DECARBOXYLASE 67; SEROTONIN TRANSPORTER; VESICULAR INHIBITORY AMINO ACID TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; GABAERGIC SYSTEM; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MOOD DISORDER; NONHUMAN; NPAS 4 GENE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

EID: 84855864633     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.326     Document Type: Erratum

References (77)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007). Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525-535.
2. Ansorge MS, Morelli E, Gingrich JA (2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28:199-207.
3. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881. (Pubitemid 39446998)
4. Bartos M, Vida I, Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45-56. (Pubitemid 46011998)
5. Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27. (Pubitemid 32493819)
6. Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151. (Pubitemid 43151600)
7. Brambilla P, Perez J, Barale F, Schettini G, Soares JC (2003). GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737, 715. (Pubitemid 36976430)
8. Calabrese F, Molteni R, Cattaneo A, Macchi F, Racagni G, Gennarelli M et al (2010). Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol 77:846-853.
9. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G et al (2007). Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32:2351-2359. (Pubitemid 47587673)
10. Calabrese F, Molteni R, Racagni G, Riva MA (2009). Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34 (Suppl 1): S208-S216.
11. Calabrese F, Molteni R, Riva MA (2011). Antistress properties of antidepressant drugs and their clinical implications. Pharmacol Ther 132:39-56.
12. Carter NJ, McCormack PL (2009). Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs 23:523-541.
13. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE (2010). Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167:509-527.
14. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389. (Pubitemid 36877077)
15. Castren E (2005). Is mood chemistry? Nat Rev Neurosci 6:241-246. (Pubitemid 40342418)
16. Castren E, Voikar V, Rantamaki T (2007). Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21. (Pubitemid 46238033)
17. Czeh B, Simon M, van der Hart MG, Schmelting B, Hesselink MB, Fuchs E (2005). Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist. Neuropsychopharmacology 30:67-79. (Pubitemid 40024401)
18. Drugan RC, Scher DM, Sarabanchong V, Guglielmi A, Meng I, Chang J et al (1992). Controllability and duration of stress alter central nervous system depressant-induced sleep time in rats. Behav Neurosci 106:682-689.
19. Gaspar P, Cases O, Maroteaux L (2003). The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012. (Pubitemid 37486676)
20. Gass P, Riva MA (2007). CREB, neurogenesis and depression. Bioessays 29:957-961. (Pubitemid 47522836)
21. Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M et al (1984). CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 141:1533-1540. (Pubitemid 15219750)
22. Gerner RH, Hare TA (1981). CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 138:1098-1101. (Pubitemid 11012815)
23. Glorioso C, Sabatini M, Unger T, Hashimoto T, Monteggia LM, Lewis DA et al (2006). Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry 11:633-648. (Pubitemid 43989811)
24. Greer PL, Greenberg ME (2008). From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59:846-860.
25. Groves JO (2007). Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088. (Pubitemid 350191365)
26. Gu YZ, Hogenesch JB, Bradfield CA (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519-561. (Pubitemid 30340692)
27. Hansen HH, Sanchez C, Meier E (1997). Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 283:1333-1341. (Pubitemid 28016508)
28. Hariri AR, Holmes A (2006). Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 10:182-191.
29. Homberg JR, Lesch KP (2011). Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 69:513-519.
30. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P et al (2011). Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One 6:el6646.
31. Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, Verheul M et al (2007). Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662-1676. (Pubitemid 46783222)
32. Huang HJ, Liang KC, Chang YY, Ke HC, Lin JY, Hsieh-Li HM (2010). The interaction between acute oligomer Abeta (1-40) and stress severely impaired spatial learning and memory. Neurobiol Learn Mem 93:8-18.
33. Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A et al (2009). Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry 195:30-38.
34. Jans LA, Riedel WJ, Markus CR, Blokland A (2007). Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522-543. (Pubitemid 46816766)
35. Kalueff AV, Olivier JD, Nonkes LJ, Homberg JR (2010). Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34:373-386.
36. Karg K, Burmeister M, Shedden K, Sen S (2011). The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation. Arch Gen Psychiatry 68:444-454.
37. Karolewicz B, Maciag D, O'Dwyer G, Stockmeier CA, Feyissa AM, Rajkowska G (2010). Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 13:411-420.
38. Kasa K, Otsuki S, Yamamoto M, Sato M, Kuroda H, Ogawa N (1982). Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry 17:877-883. (Pubitemid 12046064)
39. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature 455:894-902.
40. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G et al (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 (Suppl 1): S71-S80. (Pubitemid 34280651)
41. Lewis DA, Hashimoto T, Volk DW (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324. (Pubitemid 40469985)
42. Lin Y, Bloodgood BL, Hauser JL, Lapan AD, Koon AC, Kim TK et al (2008). Activity-dependent regulation of inhibitory synapse development by Npas4. Nature 455:1198-1204.
43. Lisboa SF, Oliveira PE, Costa LC, Venancio EJ, Moreira EG (2007). Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 80:49-56. (Pubitemid 47013367)
44. Luscher B, Shen Q, Sahir N (2011). The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383-406.
45. Martinowich K, Manji H, Lu B (2007). New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093. (Pubitemid 47339961)
46. Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S (2009). Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65:1006-1014.
47. Molteni R, Calabrese F, Cattaneo A, Mancini M, Gennarelli M, Racagni G et al (2009a). Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34:1523-1532.
48. Molteni R, Calabrese F, Maj PF, Olivier JD, Racagni G, Ellenbroek BA et al (2009b). Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats. Eur Neuropsychopharmacol 19:898-904.
49. Molteni R, Cattaneo A, Calabrese F, Macchi F, Olivier JD, Racagni G et al (2010). Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis 37:747-755.
50. Munafo MR, Durrant C, Lewis G, Flint J (2009). Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 65:211-219.
51. Murphy DL, Lesch KP (2008). Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9:85-96. (Pubitemid 351164876)
52. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613-620. (Pubitemid 34747241)
53. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372. (Pubitemid 26154346)
54. Olivier JD, Blom T, Arentsen T, Homberg JR (2010). The agedependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog Neuropsychopharmacol Biol Psychiatry 35:1400-1408.
55. Olivier JD, Valles A, van Heesch F, Afrasiab-Middelman A, Roelofs JJ, Jonkers M et al (2011). Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl) 217:419-432.
56. Olivier JD, Van der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, Cremers T et al (2008). A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152:573-584.
57. Ooe N, Saito K, Kaneko H (2009). Characterization of functional heterodimer partners in brain for a bHLH-PAS factor NXF. Biochim Biophys Acta 1789:192-197.
58. Paxinos G, Watson C (1996). The Rat Brain in Stereotaxis Coordinates, Academic Press, New York.
59. Petty F, Kramer GL, Gullion CM, Rush AJ (1992). Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry 32:354-363.
60. Pittenger C, Duman RS (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109. (Pubitemid 350191319)
61. Popa D, Lena C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28:3546-3554.
62. Pruunsild P, Sepp M, Orav E, Koppel I, Timmusk T (2011). Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci 31:3295-3308.
63. Qi X, Lin W, Li J, Li H, Wang W, Wang D et al (2008). Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 31:278-285.
64. Russo-Neustadt AA, Chen MJ (2005). Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des 11:1495-1510. (Pubitemid 40691448)
65. Sakata K, Jin L, Jha S (2010). Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav 9:712-721.
66. Sakata K, Woo NH, Martinowich K, Greene JS, Schloesser RJ, Shen L et al (2009). Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 106:5942-5947.
67. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56:1043-1047. (Pubitemid 29526389)
68. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663-665. (Pubitemid 34274953)
69. Schwaller B, Meyer M, Schiffmann S (2002). 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1:241-258. (Pubitemid 44133820)
70. Seidel K, Helmeke C, Poeggel G, Braun K (2008). Repeated neonatal separation stress alters the composition of neurochemically characterized interneuron subpopulations in the rodent dentate gyrus and basolateral amygdala. Dev Neurobiol 68:1137-1152.
71. Sen S, Duman R, Sanacora G (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64:527-532.
72. Serretti A, Kato M, De Ronchi D, Kinoshita T (2007). Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12:247-257. (Pubitemid 46328503)
73. Smits BM, Mudde JB, van de Belt J, Verheul M, Olivier J, Homberg J et al (2006). Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet Genomics 16:159-169.
74. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S et al (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20:4030-4036. (Pubitemid 30365673)
75. Tripp A, Kota RS, Lewis DA, Sibille E (2011). Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis 42:116-124.
76. Uher R, McGuffin P (2008). The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13:131-146.
77. Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, Nishiyama N et al (2002). Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 22:7580-7585. (Pubitemid 35386359)